Abingworth LLP
13F Portfolio Filings
- Most recent 13FQ4 2022
- Locationlondon, X0
- CIK0001397144
- All SEC filings
Quater | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
19 | $306.92M | PCVX, VRNA, VERA, HLVX | 13F-HR | Feb 10, 2023 | 000095012323001542 | ||
19 | $292.48M | PCVX, VERA, HLVX, ACET | 13F-HR | Nov 10, 2022 | 000095012322011475 | ||
21 | $312.40M | PCVX, SRRA, VERA, ACET | 13F-HR | Aug 15, 2022 | 000095012322008979 | ||
20 | $352.50M | PCVX, VERA, ACET, SRRA | 13F-HR | May 16, 2022 | 000095012322005945 | ||
20 | $412.70M | PCVX, VERA, JSPR, EFTR | 13F-HR | Feb 16, 2022 | 000095012322003174 | ||
20 | $440.67M | PCVX, EFTR, JSPR, VERA | 13F-HR | Nov 15, 2021 | 000095012321015091 | ||
19 | $323.50M | PCVX, PHAT, VERA, Spruce Bio | 13F-HR | Aug 16, 2021 | 000095012321011049 | ||
17 | $289.55M | PCVX, PHAT, Spruce Bio, ACET | 13F-HR | May 17, 2021 | 000095012321006642 | ||
15 | $292.33M | PCVX, Spruce Bio, PHAT, SOLENO THERAPEUTICS INC | 13F-HR | Mar 1, 2021 | 000095012321003195 | ||
17 | $467.50M | PCVX, PSNL, PHAT, SOLENO THERAPEUTICS INC | 13F-HR | Nov 16, 2020 | 000095012320011855 | ||
16 | $357.66M | PCVX, PSNL, PHAT, CRISPR THERAPEUTICS AG | 13F-HR | Aug 14, 2020 | 000095012320009033 | ||
16 | $150.58M | PSNL, PHAT, CRISPR THERAPEUTICS AG, SOLENO THERAPEUTICS INC | 13F-HR | May 14, 2020 | 000095012320004711 | ||
16 | $206.91M | PSNL, PHAT, CRISPR THERAPEUTICS AG, SIEN | 13F-HR | Feb 14, 2020 | 000095012320002010 | ||
14 | $158.15M | PSNL, CRISPR THERAPEUTICS AG, XCUR, SIEN | 13F-HR | Nov 14, 2019 | 000095012319010931 | ||
14 | $260.76M | PSNL, CRISPR THERAPEUTICS AG, SIEN, 1855568D | 13F-HR | Aug 14, 2019 | 000095012319007879 | ||
14 | $111.73M | CRISPR THERAPEUTICS AG, SIEN, CHMA, SOLENO THERAPEUTICS INC | 13F-HR | May 15, 2019 | 000095012319004991 | ||
16 | $110.06M | CRISPR THERAPEUTICS AG, SIEN, VRNA, SOLENO THERAPEUTICS INC | 13F-HR | Feb 14, 2019 | 000095012319001785 | ||
16 | $168.20M | CRISPR THERAPEUTICS AG, SIEN, VRNA, PRTK | 13F-HR | Nov 14, 2018 | 000095012318011490 | ||
16 | $175.04M | CRISPR THERAPEUTICS AG, SIEN, PRTK, OBSEVA SA | 13F-HR | Aug 14, 2018 | 000095012318008483 | ||
16 | $160.87M | CRISPR THERAPEUTICS AG, SIEN, PRTK, GTX INC DEL | 13F-HR | May 15, 2018 | 000095012318005361 | ||
17 | $138.02M | CRISPR THERAPEUTICS AG, SIEN, PRTK, CBAY | 13F-HR | Feb 14, 2018 | 000095012318001868 | ||
18 | $144.44M | CRISPR THERAPEUTICS AG, SIEN, PRTK, CBAY | 13F-HR | Nov 14, 2017 | 000095012317010459 | ||
16 | $125.66M | CRISPR THERAPEUTICS AG, PRTK, SIEN, CBAY | 13F-HR | Aug 14, 2017 | 000095012317007534 | ||
17 | $134.22M | CRISPR THERAPEUTICS AG, PRTK, SIEN, CBAY | 13F-HR | May 15, 2017 | 000095012317004984 | ||
18 | $119.63M | CRISPR THERAPEUTICS AG, PRTK, SIEN, NOVN | 13F-HR | Feb 14, 2017 | 000095012317001929 | ||
20 | $104.33M | SIEN, PRTOEUR, PRTK, CEMPRA INC | 13F-HR | Nov 14, 2016 | 000095012316021952 | ||
20 | $95.50M | PRTK, PRTOEUR, SIEN, TOBIRA THERAPEUTICS INC | 13F-HR | Aug 12, 2016 | 000095012316019505 | ||
19 | $107.62M | PRTK, CHMA, PRTOEUR, SIEN | 13F-HR | May 13, 2016 | 000095012316017004 | ||
18 | $165.70M | CHMA, PRTOEUR, PRTK, SIEN | 13F-HR | Feb 16, 2016 | 000095012316014690 | ||
17 | $171.21M | CHMA, PRTOEUR, PRTK, SIEN | 13F-HR | Nov 13, 2015 | 000095012315011710 | ||
16 | $220.34M | SIEN, PRTOEUR, PRTK, EH3A | 13F-HR | Aug 14, 2015 | 000095012315009063 | ||
17 | $235.18M | SIEN, PRTK, SUPN, DRNA | 13F-HR | May 14, 2015 | 000095012315005781 | ||
16 | $352.09M | PROSENSA HLDG N V, PRTK, SIEN, PTLA | 13F-HR | Feb 13, 2015 | 000095012315001866 | ||
13 | $167.25M | PROSENSA HLDG N V, LOMBARD MED INC, SUPN, PTLA | RESTATEMENT | Nov 25, 2014 | 000095012314012543 | ||
12 | $215.20M | PROSENSA HLDG N V, SUPN, PTLA, DRNA | 13F-HR | Aug 14, 2014 | 000095012314008800 | ||
13 | $181.25M | PROSENSA HLDG N V, DRNA, SUPN, PTLA | 13F-HR | May 21, 2014 | 000095012314006465 | ||
11 | $132.70M | PTLA, PROSENSA HLDG N V, SUPN, EH3A | 13F-HR | Feb 14, 2014 | 000095012314002352 |